MYCN amplification and International Neuroblastoma Risk Group stratification on fine-needle aspiration biopsy and their correlation to survival in neuroblastoma

被引:3
作者
Bhardwaj, Neha [1 ]
Rohilla, Manish [2 ]
Trehan, Amita [3 ]
Bansal, Deepak [3 ]
Kakkar, Nandita [4 ]
Srinivasan, Radhika [2 ]
机构
[1] Post Grad Inst Med Educ & Res, Pathol, Chandigarh, India
[2] Post Grad Inst Med Educ & Res, Cytol & Gynecol Pathol, Chandigarh 160012, India
[3] Post Grad Inst Med Educ & Res, Dept Pediat Hematol Oncol Div, Chandigarh, India
[4] Post Grad Inst Med Educ & Res, Histopathol, Chandigarh, India
关键词
NEUROBLASTOMA; FISH; Pathology; Molecular; N-MYC; GENE AMPLIFICATION; NEURO-BLASTOMA; CYTOLOGY; CLASSIFICATION; DIAGNOSIS; CELL; ONCOGENE; CHILDREN; TUMOR;
D O I
10.1136/jclinpath-2022-208177
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims Risk stratification as per the International Neuroblastoma Risk Group (INRG) stratification is important for management of neuroblastoma. INRG incorporates various parameters including histological category as per the International Neuroblastoma Pathology Classification (INPC) and MYCN amplification, which were evaluated in fine needle aspiration biopsy (FNAB) samples of neuroblastoma patients to ascertain their impact in our population. Methods This was a retrospective study including 60 neuroblastoma cases diagnosed on FNAB, staged and stratified by INRG. Mitosis Karyorrhexis Index (MKI), INPC morphological category and MYCN status by fluorescence in situ hybridisation (n=46) were evaluated and correlated to outcome. Results The mean age was 29 months (21 days to 9 years) with 27 and 33 children </>= 18 months; male: female ratio of 1.6: 1; INRG stage-30(M), 20(L2), 2(L1) and 2(MS); INRG-36 high-risk, 13 intermediate-risk and 11 low-risk categories, respectively. MKI was high, intermediate and low in 39, 4 and 7 cases, respectively. INPC morphological type included 2 ganglioneuroblastomas and 58 neuroblastomas, graded further as 25 undifferentiated and 33 poorly differentiated tumours. MYCN was amplified in 48% (22/46) cases and correlated with undifferentiated morphology (p=0.01). At a mean follow-up of 469 (7-835) days, 22/50 were disease free and 28/50 had relapsed/died. The overall survival correlated with age (p=0.03), stage (p=0.01), INRG group (p=0.0001) and tumour grade (p=0.036). MYCN status independently did not correlate with age (p=0.5), INRG stage (p=0.2) and overall survival (p=0.4). Conclusion FNAB is a complete modality for diagnosing neuroblastoma and providing all information required for risk stratification as per INRG including MKI, MYCN amplification, INPC category. Our cohort with predominant high-risk neuroblastoma cases highlights regional variation.
引用
收藏
页码:599 / 605
页数:7
相关论文
共 39 条
[11]   AMPLIFICATION OF N-MYC IN UNTREATED HUMAN NEUROBLASTOMAS CORRELATES WITH ADVANCED DISEASE STAGE [J].
BRODEUR, GM ;
SEEGER, RC ;
SCHWAB, M ;
VARMUS, HE ;
BISHOP, JM .
SCIENCE, 1984, 224 (4653) :1121-1124
[12]   REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].
BRODEUR, GM ;
PRITCHARD, J ;
BERTHOLD, F ;
CARLSEN, NLT ;
CASTEL, V ;
CASTLEBERRY, RP ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
HEDBORG, F ;
KANEKO, M ;
KEMSHEAD, J ;
LAMPERT, F ;
LEE, REJ ;
LOOK, AT ;
PEARSON, ADJ ;
PHILIP, T ;
ROALD, B ;
SAWADA, T ;
SEEGER, RC ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477
[13]   Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project [J].
Campbell, Kevin ;
Shyr, Derek ;
Bagatell, Rochelle ;
Fischer, Matthias ;
Nakagawara, Akira ;
Canete Nieto, Adela ;
Brodeur, Garrett M. ;
Matthay, Katherine K. ;
London, Wendy B. ;
DuBois, Steven G. .
PEDIATRIC BLOOD & CANCER, 2019, 66 (08)
[14]   The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report [J].
Cohn, Susan L. ;
Pearson, Andrew D. J. ;
London, Wendy B. ;
Monclair, Tom ;
Ambros, Peter F. ;
Brodeur, Garrett M. ;
Faldum, Andreas ;
Hero, Barbara ;
Iehara, Tomoko ;
Machin, David ;
Mosseri, Veronique ;
Simon, Thorsten ;
Garaventa, Alberto ;
Castel, Victoria ;
Matthay, Katherine K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) :289-297
[15]   Childhood Cancer Incidence in India Betweem 2012 and 2014: Report of a Population-based Cancer Registry [J].
Das, Suman ;
Paul, Dilip Kumar ;
Anshu, Kumar ;
Bhakta, Subhajit .
INDIAN PEDIATRICS, 2017, 54 (12) :1033-1036
[16]   N-MYC AMPLIFICATION IN MULTIPLE HOMOGENEOUSLY STAINING REGIONS IN 2 HUMAN NEUROBLASTOMAS [J].
EMANUEL, BS ;
BALABAN, G ;
BOYD, JP ;
GROSSMAN, A ;
NEGISHI, M ;
PARMITER, A ;
GLICK, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) :3736-3740
[17]   The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours [J].
Fröstad, B ;
Tani, E ;
Kogner, P ;
Maeda, S ;
Björk, O ;
Skoog, L .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (04) :529-536
[18]   Autologous stem cell transplant for high-risk neuroblastoma: Achieving cure with low-cost adaptations [J].
Jain, Richa ;
Hans, Rekha ;
Totadri, Sidharth ;
Trehan, Amita ;
Sharma, Ratti Ram ;
Menon, Prema ;
Kapoor, Rakesh ;
Saxena, Akshay Kumar ;
Mittal, Bhagwant Rai ;
Bhatia, Prateek ;
Kakkar, Nandita ;
Srinivasan, Radhika ;
Rajwanshi, Arvind ;
Varma, Neelam ;
Samujh, Ram ;
Marwaha, Neelam ;
Bansal, Deepak .
PEDIATRIC BLOOD & CANCER, 2020, 67 (06)
[19]   Diagnostic and Prognostic Information Obtained on Fine-Needle Aspirates of Primary Neuroblastic Tumors Proposal for a Cytology Prognostic Score [J].
Klijanienko, Jerzy ;
Couturier, Jerome ;
Brisse, Herve ;
Pierron, Gaelle ;
Freneaux, Paul ;
Berger, Frederique ;
Maciorowski, Zofia ;
Sastre-Garau, Xavier ;
Michon, Jean ;
Schleiermacher, Gudrun .
CANCER CYTOPATHOLOGY, 2011, 119 (06) :411-423
[20]   TRANSPOSITION AND AMPLIFICATION OF ONCOGENE-RELATED SEQUENCES IN HUMAN NEUROBLASTOMAS [J].
KOHL, NE ;
KANDA, N ;
SCHRECK, RR ;
BRUNS, G ;
LATT, SA ;
GILBERT, F ;
ALT, FW .
CELL, 1983, 35 (02) :359-367